Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Legos

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Update on pharmacological strategies for stroke: prevention, acute intervention and regenerationJeffrey J Legos, Frank C Barone
Expert Opinion on Investigational Drugs|May 9, 2002
Pharmacological interventions for stroke: failures and futureJeffrey J Legos, Ronald F Tuma, Frank C Barone
Expert Opinion on Investigational Drugs|April 2, 2002
Non-surgical management of spinal cord injuryJeffrey J Legos, Jonas J Gopez, William F Young
Microvascular Research|April 24, 2002
LEX032, a novel recombinant serpin, protects the brain after transient focal ischemiaMichael Weaver, Karin Leshley, Howard Sands, et al.
Pharmacology|August 30, 2007
Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and miceFrank C Barone, Matthew E Barton, Ray F White, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2003
Caspase 3 activation is essential for neuroprotection in preconditioningBethAnn McLaughlin, Karen A Hartnett, Joseph A Erhardt, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 25, 2010
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic miceMichael K Hansen, Matthew J McVey, Ray F White, et al.
Journal of Neuroscience Methods|January 5, 2002
Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the ratJeffrey J Legos, Arduino A Mangoni, Simon J Read, et al.
European Journal of Pharmacology|July 11, 2002
The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injuryJeffrey J Legos, BethAnn McLaughlin, Stephen D Skaper, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2007
Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy studyBeat M Jucker, Dewen Yang, Warren M Casey, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
Update on pharmacological strategies for stroke: prevention, acute intervention and regenerationJeffrey J Legos, Frank C Barone
Expert Opinion on Investigational Drugs|May 9, 2002
Pharmacological interventions for stroke: failures and futureJeffrey J Legos, Ronald F Tuma, Frank C Barone
Expert Opinion on Investigational Drugs|April 2, 2002
Non-surgical management of spinal cord injuryJeffrey J Legos, Jonas J Gopez, William F Young
Microvascular Research|April 24, 2002
LEX032, a novel recombinant serpin, protects the brain after transient focal ischemiaMichael Weaver, Karin Leshley, Howard Sands, et al.
Pharmacology|August 30, 2007
Inhibition of phosphodiesterase type 4 decreases stress-induced defecation in rats and miceFrank C Barone, Matthew E Barton, Ray F White, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2003
Caspase 3 activation is essential for neuroprotection in preconditioningBethAnn McLaughlin, Karen A Hartnett, Joseph A Erhardt, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|March 25, 2010
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic miceMichael K Hansen, Matthew J McVey, Ray F White, et al.
Journal of Neuroscience Methods|January 5, 2002
Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the ratJeffrey J Legos, Arduino A Mangoni, Simon J Read, et al.
European Journal of Pharmacology|July 11, 2002
The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injuryJeffrey J Legos, BethAnn McLaughlin, Stephen D Skaper, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 30, 2007
Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy studyBeat M Jucker, Dewen Yang, Warren M Casey, et al.
Pageof 2